Mark Schiller
Psychiatry · Corte Madera, CANPI 1245445170
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 258 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,244, 2.1 times the $584 reported in 2019. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 258 payments — averaging $22.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alkermes, Inc.$881
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$659
- Lundbeck LLC$647
- Indivior Inc.$574
- Takeda Pharmaceuticals U.S.A., Inc.$232
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,62699%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 59 | $1,014 |
| Alkermes, Inc. | 34 | $881 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $659 |
| Lundbeck LLC | 29 | $647 |
| Indivior Inc. | 23 | $574 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $232 |
| Otsuka America Pharmaceutical, Inc. | 10 | $223 |
| Teva Pharmaceuticals USA, Inc. | 7 | $213 |
| Johnson & Johnson | 9 | $207 |
| Axsome Therapeutics, Inc. | 7 | $204 |
| E.r. Squibb & Sons, L.L.C. | 3 | $187 |
| Sunovion Pharmaceuticals Inc. | 17 | $148 |
| Vanda Pharmaceuticals Inc. | 5 | $129 |
| Braeburn Inc. | 2 | $76 |
| Neurocrine Biosciences, Inc. | 2 | $59 |
| Orexo US, Inc. | 3 | $52 |
| Merck | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Alfasigma USA, Inc. | 1 | $18 |
| MDD US Operations, LLC | 1 | $16 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,676 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylphenidate ErMethylphenidate Hcl | 18 | $1,859 |
| Gabapentin | 48 | $1,002 |
| Bupropion XlBupropion Hcl | 39 | $740 |
| Quetiapine Fumarate | 12 | $402 |
| Lurasidone Hcl | 16 | $386 |
| Buspirone Hcl | 14 | $342 |
| Mirtazapine | 37 | $328 |
| Trazodone Hcl | 46 | $318 |
| Alprazolam | 26 | $255 |
| Lithium Carbonate ErLithium Carbonate | 13 | $192 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $139 |
| Escitalopram Oxalate | 11 | $95 |
| Clonazepam | 27 | $72 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Corte Madera
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.